Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 413.50
+0.50 (0.12%)
Oct 21, 2026, 1:30 PM CST
Bora Pharmaceuticals Market Cap
Bora Pharmaceuticals has a market cap or net worth of 52.63 billion as of October 20, 2026. It is the 7,604th most valuable company in the world and the 218th biggest in Taiwan. Its market cap has decreased by 33.84% in one year.
Market Cap
52.63B
Enterprise Value
68.37B
Revenue
19.56B
Global Rank
Country Rank
#218 Taiwan
PE Ratio
44.45
ChartMarket Cap Chart
Since October 3, 2014, Bora Pharmaceuticals's market cap has increased from 3.16B to 52.63B, an increase of 1,564.63%. That is a compound annual growth rate of 26.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 52.63B | -13.04% |
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 47.20B |
| Center Laboratories | 23.65B |
| Handa Pharmaceuticals | 21.29B |
| TTY Biopharm Company | 20.04B |
| Synmosa Biopharma | 15.91B |
| YungShin Global Holding | 15.69B |
| ScinoPharm Taiwan | 15.18B |
| Grape King Bio | 12.73B |